COVID-19

New study shows opportunity exists to make healthcare more durable to further long-term gains in preparedness for emergencies like COVID-19.

In the space of 2 days, the FDA approved at-home oral treatments for patients with mild-to-moderate COVID-19, drug that were months in development. Today, it was Merck and Ridgeback Biotherapeutics’ turn.

The pill, Paxlovid, showed an 88% decrease in hospitalization and death for those taking it 5 days after experiencing COVID-19 symptoms.

The Johnson & Johnson vaccine is staying on the market, but the preference for the Pfizer and Moderna mRNA vaccines stems from concerns about the rare but real risk of blood clots from the J&J vaccine.

The company says a third dose of their COVID-19 vaccine is effective against the latest variant of the disease.

COVID-19 updates and news to know as of December 20, 2021.

Take a look back at the top 10 COVID-19 news articles published on Drug Topics® this year.

An alarming amount of COVID-19 disinformation is prevalent, even from health care providers.

COVID-19 updates and news to know as of December 16, 2021.

A number of studies evaluated how COVID-19 infection and vaccination impact patients living with blood cancers and other blood disorders.

Individuals aged 16 or 17 years may now receive a single booster dose at least 6 months after completion of their primary vaccination series.

Influenza is expected to make a comeback this year, and no one knows how severe it may be.

Prescription fills decreased most significantly in a subgroup of adults.

Mean days of therapy per 1000 patient-days were reduced across medication categories.

COVID-19 updates and news to know as of December 6, 2021.

At some independent pharmacies, pharmacists are voluntarily working longer, unrecorded hours to provide patient care.

The US Food and Drug Administration (FDA) is currently investigating whether the new COVID-19 variant will evade current mitigation strategies and diagnostic tools.

Educate patients about the safety of receiving the seasonal influenza and COVID-19 vaccine at the same time.

Kristen Nichols, PharmD, and senior content management consultant for clinical effectiveness at Wolters Kluwer joins Drug Topics® to discuss the benefits of the coadministration of COVID-19 and flu vaccines in part 2 of this interview.

The Omicron variant was first identified in South Africa on November 24, 2021.

The Omicron variant of COVID-19 is spreading quickly, jumping continents through infected travelers. Here’s the latest on what global health officials know.

Non-hospitalized symptomatic COVID-19 patients who were treated with ciclesonide to alleviate early symptoms did not see any difference in results compared to patients who were treated with a placebo of the drug.

Nearly one-third of hospital personnel had still not been vaccinated against COVID-19 by mid-September.

The EUA amendment was granted for both the Pfizer-BioNTech and Moderna vaccines.

The EUA submission includes data from the company’s interim analysis of the Phase 2/3 EPIC-HR clinical trial.